{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:00:13Z","timestamp":1789052413921,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":855,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1111\/jth.14815","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:55:10Z","timestamp":1585799710000},"page":"1686-1694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A multi\u2010center evaluation of TECHNOSCREEN\u00ae ADAMTS\u201013 activity assay as a screening tool for detecting deficiency of ADAMTS\u201013"],"prefix":"10.1016","volume":"18","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Rushen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Leyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Geiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Moes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14815_bb0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bjh.13654","article-title":"The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry","volume":"171","author":"Hassan","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14815_bb0015","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14815_bb0020","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14815_bb0025","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.14815_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14815_bb0035","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor\u2010cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2010uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14815_bb0040","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/bjh.15219","article-title":"The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura","volume":"184","author":"Thomas","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14815_bb0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","article-title":"ADAMTS\u201013 assays in thrombotic thrombocytopenic purpura","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14815_bb0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","article-title":"Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura","volume":"56","author":"Connell","year":"2016","journal-title":"Transfusion"},{"key":"10.1111\/jth.14815_bb0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5858\/arpa.2013-0170-OA","article-title":"Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura","volume":"138","author":"Barrows","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.14815_bb0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14815_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1309\/LM749BQETKYPYPVM","article-title":"Pre\u2010analytical variables in coagulation testing associated with diagnostic errors in hemostasis","volume":"43","author":"Favaloro","year":"2012","journal-title":"Lab Med"},{"key":"10.1111\/jth.14815_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12959-016-0123-z","article-title":"Pre\u2010analytical issues in the haemostasis laboratory: guidance for the clinical laboratories","volume":"14","author":"Magnette","year":"2016","journal-title":"Thromb J"},{"key":"10.1111\/jth.14815_bb0075","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood\u2010onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross\u2010sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1111\/jth.14815_bb0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody\u2010based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/jth.14815_bb0085","series-title":"User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline \u2013 Second Edition","year":"2008"},{"key":"10.1111\/jth.14815_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"10.1111\/jth.14815_bb0095","unstructured":"ECAT Foundation. Report on survey 2019\u2010M2. https:\/\/www.ecat.nl\/survey\u2010reports\u2010survey\u20102019\u2010m2\/. Accessed April 9, 2020."},{"key":"10.1111\/jth.14815_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijlh.12718","article-title":"Multiple centre evaluation study of ADAMTS13 activity and inhibitor assays","volume":"40","author":"Langley","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.14815_bb0105","series-title":"Proof and Concepts in Rapid Diagnostic Tests and Technologies","first-page":"139","article-title":"Evaluation of rapid diagnostic test performance","author":"Pereira","year":"2016"},{"key":"10.1111\/jth.14815_bb0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH12-08-0565","article-title":"Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies","volume":"109","author":"Mackie","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14815_bb0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ijlh.12542","article-title":"Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test","volume":"38","author":"Nakashima","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.14815_bb0120","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.thromres.2014.09.006","article-title":"Evaluation of a chromogenic commercial assay using VWF\u201073 peptide for ADAMTS13 activity measurement","volume":"134","author":"Joly","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14815_bb0125","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2005.01425.x","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"L\u00e4mmle","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14815_bb0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.12569","article-title":"Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)","volume":"163","author":"Shah","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14815_bb0135","doi-asserted-by":"crossref","first-page":"E644","DOI":"10.1002\/ajh.24885","article-title":"Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 activity 10%\u201020%","volume":"92","author":"Ayanambakkam","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14815_bb0140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2001-12-0166","article-title":"von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"100","author":"Remuzzi","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.14815_bb0145","series-title":"Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics","first-page":"38","article-title":"Preanalytical variation","author":"Simundic","year":"2019"},{"key":"10.1111\/jth.14815_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.11613\/BM.2014.008","article-title":"Lipemia: causes, interference mechanisms, detection and management","volume":"24","author":"Nikolac","year":"2014","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1111\/jth.14815_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"key":"10.1111\/jth.14815_bb0160","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1111\/jth.14815_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/rth2.12160","article-title":"Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine","volume":"3","author":"Coppo","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14815_bb0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1641151","article-title":"Evaluation of the fully automated HemosIL Acustar ADAMTS13 activity assay","volume":"118","author":"Favresse","year":"2018","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/jth.14815_bb0175","first-page":"739","article-title":"Feasibility of a new fully automated ADAMTS\u201013 activity assay","volume":"3","author":"Llusa","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14815_bb0180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.transci.2006.08.006","article-title":"ADAMTS\u201013 levels in fresh, stored, and solvent detergent treated plasma","volume":"35","author":"Rock","year":"2006","journal-title":"Transfus Apher Sci"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14815","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14815","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14815","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:23Z","timestamp":1761535763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622013307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1538783622013307"],"URL":"https:\/\/doi.org\/10.1111\/jth.14815","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi\u2010center evaluation of TECHNOSCREEN\u00ae ADAMTS\u201013 activity assay as a screening tool for detecting deficiency of ADAMTS\u201013","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}